We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
-4.11%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$3.1B
AUM Growth
-$238M
Cap. Flow
-$59.4M
Cap. Flow %
-1.92%
Top 10 Hldgs %
43.18%
Holding
179
New
2
Increased
27
Reduced
96
Closed
7

Top Buys

Rank Stock Value
1
FERG icon
Ferguson
FERG
+$22.8M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$9.48M
3
OWL icon
Blue Owl Capital
OWL
+$2.82M
4
SHW icon
Sherwin-Williams
SHW
+$1.87M
5
HLT icon
Hilton Worldwide
HLT
+$1.76M

Sector Composition

Rank Sector Weight
1 Financials 38.96%
2 Healthcare 14.34%
3 Technology 13.21%
4 Communication Services 8.71%
5 Industrials 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.9T
$200M 6.45%
858,143
-3,711
-0.4% -$980K
BX icon
2
Blackstone
BX
$104B
$196M 6.34%
2,344,629
-3,831
-0.2% -$371K
APO icon
3
Apollo Global Management
APO
$69B
$146M 4.72%
3,145,101
-50,678
-2% -$2.78M
CACC icon
4
Credit Acceptance
CACC
$5.82B
$140M 4.5%
318,510
-15
-0% -$7.92K
AJG icon
5
Arthur J. Gallagher & Co
AJG
$69.1B
$119M 3.85%
696,385
+150
+0% +$26.6K
ESGR
6
DELISTED
Enstar Group
ESGR
$115M 3.7%
676,239
-3,131
-0.5% -$611K
GOOG icon
7
Alphabet (Google) Class C
GOOG
$4.11T
$110M 3.54%
1,140,908
+2,008
+0.2% +$224K
SCHW
8
Charles Schwab
SCHW
$182B
$110M 3.54%
1,523,826
-6,594
-0.4% -$458K
LH icon
9
Labcorp
LH
$25.2B
$97.3M 3.14%
553,063
-4,521
-0.8% -$926K
ROP icon
10
Roper Technologies
ROP
$40.4B
$77.5M 2.5%
215,518
-2,430
-1% -$989K
ABT icon
11
Abbott
ABT
$188B
$75.3M 2.43%
778,249
-2,408
-0.3% -$257K
EPD icon
12
Enterprise Products Partners
EPD
$83.7B
$65M 2.1%
2,732,677
+9,460
+0.3% +$244K
WAT icon
13
Waters Corp
WAT
$37.3B
$62.3M 2.01%
231,236
-1,439
-0.6% -$459K
RDNT icon
14
RadNet
RDNT
$4.98B
$61.5M 1.99%
3,022,341
+2,023
+0.1% +$40.8K
TEVA icon
15
Teva Pharmaceuticals
TEVA
$40.4B
$60.8M 1.96%
7,536,985
+1,072,190
+17% +$9.48M
JEF icon
16
Jefferies Financial Group
JEF
$12.7B
$57.7M 1.86%
2,045,266
-22,612
-1% -$684K
CSGP icon
17
CoStar Group
CSGP
$12.2B
$54.5M 1.76%
782,061
+2,031
+0.3% +$141K
GOOGL icon
18
Alphabet (Google) Class A
GOOGL
$4.12T
$52.5M 1.7%
549,338
-16,842
-3% -$1.87M
JPM icon
19
JPMorgan Chase
JPM
$916B
$51.5M 1.66%
492,905
-12,564
-2% -$1.44M
MTDR icon
20
Matador Resources
MTDR
$6.04B
$49.9M 1.61%
1,019,999
-1,882
-0.2% -$102K
BRK.B icon
21
Berkshire Hathaway Class B
BRK.B
$1.1T
$49.4M 1.59%
184,939
-2,050
-1% -$583K
QCOM icon
22
Qualcomm
QCOM
$164B
$49.2M 1.59%
435,361
-4,642
-1% -$638K
MKL icon
23
Markel Group
MKL
$25.2B
$47.9M 1.55%
44,224
+42
+0.1% +$51.2K
JNJ icon
24
Johnson & Johnson
JNJ
$640B
$47.1M 1.52%
288,379
-3,541
-1% -$599K
FISV
25
Fiserv Inc
FISV
$29.7B
$46.6M 1.51%
498,309
+2,874
+0.6% +$293K

Similar funds

Beck Mack & Oliver's Q3 2022 Portfolio in Review

As of Q3 2022, Beck Mack & Oliver held 179 positions worth $3.1B, down 7.1% from $3.33B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Beck Mack & Oliver's Q3 2022 filing shows 2 new, 27 increased, 96 reduced and 7 closed positions. Its largest new stake was HCA Healthcare: 1,095 shares worth $201K. The largest sale was CAE Inc. Common Shares, an estimated $53.2M.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 38% a quarter earlier, followed by Healthcare and Technology.

  • Beck Mack & Oliver's largest Q3 2022 buy was HCA Healthcare: 1,095 shares worth $201K.
  • Beck Mack & Oliver added most to Ferguson in Q3 2022, an estimated $22.8M increase.
  • Beck Mack & Oliver's biggest Q3 2022 reduction was CAE Inc. Common Shares, cutting an estimated $53.2M.
  • Beck Mack & Oliver fully exited Helen of Troy in Q3 2022, selling an estimated $568K.
  • Beck Mack & Oliver's ten largest holdings make up 43% of its $3.1B portfolio in Q3 2022.
  • Beck Mack & Oliver opened 2 new positions and closed 7 in Q3 2022.
  • Beck Mack & Oliver's portfolio value fell 7.1% quarter-over-quarter to $3.1B.

Based on Beck Mack & Oliver's 13F filing for Q3 2022, filed 10 Nov 2022.